本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Wave Life Sciences Pte. Ltd

4.44
-0.0650-1.44%
盤後4.460.0200+0.45%19:33 EDT
成交量:217.18萬
成交額:979.04萬
市值:8.75億
市盈率:-4.12
高:4.65
開:4.59
低:4.42
收:4.51
52周最高:21.73
52周最低:4.40
股本:1.97億
流通股本:9,476.50萬
量比:0.82
換手率:2.29%
股息:- -
股息率:- -
每股收益(TTM):-1.0766
每股收益(LYR):-1.2118
淨資產收益率:-67.42%
總資產收益率:-33.60%
市淨率:1.93
市盈率(LYR):-3.66

資料載入中...

2025/12/08

關聯方擬減持公告

Form 144 | WAVE LIFE SCIENCES LTD.董事 Gregory Verdine 擬減持20,000股,市值約149,800美元
2025/12/08

關聯方擬減持公告

Form 144 | WAVE LIFE SCIENCES LTD.高管 Kyle Moran 擬減持210,000股,總價約157.29萬美元
2025/12/08

關聯方擬減持公告

Form 144 | WAVE LIFE SCIENCES LTD.高管 Christopher Francis 擬減持483602股,總價約362萬美元
2025/12/08

關聯方擬減持公告

Form 144 | Wave Life Sciences董事 Adrian Rawcliffe 擬減持42000股,總價約31萬美元
2025/12/08

關聯方擬減持公告

Form 144 | Wave Life Sciences高管 Heidi L Wagner 擬減持14000股,總價約104860美元
2025/12/08

關聯方擬減持公告

Form 144 | WAVE LIFE高管Mark C.擬減持16115股,總市值約12萬美元
2025/12/08

關聯方擬減持公告

Form 144 | Wave Life Sciences Ltd. 董事 Aik Na Tan 擬減持134218股,總價約182萬美元
2025/12/08

重要事件披露

Form 8-K - Current report
2025/11/17

重要事件披露

Form 8-K - Current report
2025/11/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/10

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/11/10

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/11/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/10

重要事件披露

Form 8-K - Current report
2025/10/30

重要事件披露

Form 8-K/A - Current report: [Amend]
2025/10/29

重要事件披露

Form 8-K - Current report
2025/09/24

重要事件披露

Form 8-K - Current report
2025/09/03

重要事件披露

Form 8-K - Current report
2025/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities